Osteosarcoma of the head and neck: Meta-analysis of nonrandomized studies
Osteosarcoma of the head and neck: Meta-analysis of nonrandomized studies
复制标题
DOI：
10.1097/00005537-199701000-00013
复制
发表时间：
1997-01-01
期刊：
影响因子：
2.6
通讯作者：
Hokanson, JA
中科院分区：
文献类型：
--
作者：
Kassir, RR;Rassekh, CH;Hokanson, JA
为了评估辅助治疗在头颈部骨肉瘤治疗中的作用，将173例头颈部骨肉瘤患者的治疗和生存信息输入数据库。试图对数据进行荟萃分析，主要强调辅助治疗对疾病结局的影响。5年总生存率为37%，下颌骨和上颌骨肿瘤患者的生存率相似，两组均明显优于颌外肿瘤患者（P
To assess the role of adjuvant therapy in the treatment of osteogenic sarcoma of the head and neck, treatment and survival information from 173 patients with osteosarcoma of the head and neck was entered into a database. A meta-analysis of the data was attempted with primary emphasis on the effect of adjuvant therapy on disease outcome. The overall 5-year survival was 37%, Patients with mandibular and maxillary tumors had similar survival rates; both groups fared significantly better than patients with extragnathic tumors (P